Physician communication about the cost and acquisition of newly prescribed medications

Derjung M. Tarn, Debora A Paterniti, John Heritage, Ron D. Hays, Richard L Kravitz, Neil S. Wenger

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objective: To describe the frequency and content of physician discussions about the cost and acquisition of new medications. Study Design: Qualitative and quantitative study combining patient and physician surveys with transcribed audiotaped office visits from 185 outpatient encounters with 15 family physicians, 18 internists, and 11 cardiologists in 2 Sacramento healthcare systems between January and November 1999, in which 243 new medications were prescribed, Methods: Transcripts were qualitatively analyzed to describe conversations concerning the cost and acquisition of new medication prescriptions, frequencies of discussions were described, and multivariate logistic regression was used to examine the predictors of cost discussions. Results: For one third of newly prescribed medications, physicians discussed an aspect of acquisition, including cost and insurance coverage for 12%, logistics of obtaining medications for 18%, and medication supply for 9%. Patients initiated cost or insurance concerns for fewer than 2% of the new medications prescribed. There were 5 discussions about patient out-of-pocket costs and 7 discussions offering tips for cost savings. In multivariate analysis, cost discussions were more likely to occur with patients earning less than $20 000 per year compared with those earning more than $60 000 per year, were less likely to occur with medications prescribed by family physicians or internists compared with cardiologists, and were less likely with medications prescribed to older patients. Conclusions: Physician-patient discussions about new medication cost and other acquisition issues, especially medication affordability, occur infrequently. Because physicians may not recognize patients' financial impediments to acquiring medications, this issue should be raised when prescribing new medications.

Original languageEnglish (US)
Pages (from-to)657-664
Number of pages8
JournalAmerican Journal of Managed Care
Volume12
Issue number11
StatePublished - Oct 2006

Fingerprint

medication
Communication
physician
Physicians
Costs and Cost Analysis
communication
costs
Family Physicians
Office Visits
family physician
Insurance Coverage
Cost Savings
Health Expenditures
Insurance
Prescriptions
Outpatients
Multivariate Analysis
Logistic Models
logistics
Delivery of Health Care

ASJC Scopus subject areas

  • Nursing(all)
  • Medicine(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Physician communication about the cost and acquisition of newly prescribed medications. / Tarn, Derjung M.; Paterniti, Debora A; Heritage, John; Hays, Ron D.; Kravitz, Richard L; Wenger, Neil S.

In: American Journal of Managed Care, Vol. 12, No. 11, 10.2006, p. 657-664.

Research output: Contribution to journalArticle

Tarn, Derjung M. ; Paterniti, Debora A ; Heritage, John ; Hays, Ron D. ; Kravitz, Richard L ; Wenger, Neil S. / Physician communication about the cost and acquisition of newly prescribed medications. In: American Journal of Managed Care. 2006 ; Vol. 12, No. 11. pp. 657-664.
@article{f311f141823643efa3cbbfe3bd418c98,
title = "Physician communication about the cost and acquisition of newly prescribed medications",
abstract = "Objective: To describe the frequency and content of physician discussions about the cost and acquisition of new medications. Study Design: Qualitative and quantitative study combining patient and physician surveys with transcribed audiotaped office visits from 185 outpatient encounters with 15 family physicians, 18 internists, and 11 cardiologists in 2 Sacramento healthcare systems between January and November 1999, in which 243 new medications were prescribed, Methods: Transcripts were qualitatively analyzed to describe conversations concerning the cost and acquisition of new medication prescriptions, frequencies of discussions were described, and multivariate logistic regression was used to examine the predictors of cost discussions. Results: For one third of newly prescribed medications, physicians discussed an aspect of acquisition, including cost and insurance coverage for 12{\%}, logistics of obtaining medications for 18{\%}, and medication supply for 9{\%}. Patients initiated cost or insurance concerns for fewer than 2{\%} of the new medications prescribed. There were 5 discussions about patient out-of-pocket costs and 7 discussions offering tips for cost savings. In multivariate analysis, cost discussions were more likely to occur with patients earning less than $20 000 per year compared with those earning more than $60 000 per year, were less likely to occur with medications prescribed by family physicians or internists compared with cardiologists, and were less likely with medications prescribed to older patients. Conclusions: Physician-patient discussions about new medication cost and other acquisition issues, especially medication affordability, occur infrequently. Because physicians may not recognize patients' financial impediments to acquiring medications, this issue should be raised when prescribing new medications.",
author = "Tarn, {Derjung M.} and Paterniti, {Debora A} and John Heritage and Hays, {Ron D.} and Kravitz, {Richard L} and Wenger, {Neil S.}",
year = "2006",
month = "10",
language = "English (US)",
volume = "12",
pages = "657--664",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "11",

}

TY - JOUR

T1 - Physician communication about the cost and acquisition of newly prescribed medications

AU - Tarn, Derjung M.

AU - Paterniti, Debora A

AU - Heritage, John

AU - Hays, Ron D.

AU - Kravitz, Richard L

AU - Wenger, Neil S.

PY - 2006/10

Y1 - 2006/10

N2 - Objective: To describe the frequency and content of physician discussions about the cost and acquisition of new medications. Study Design: Qualitative and quantitative study combining patient and physician surveys with transcribed audiotaped office visits from 185 outpatient encounters with 15 family physicians, 18 internists, and 11 cardiologists in 2 Sacramento healthcare systems between January and November 1999, in which 243 new medications were prescribed, Methods: Transcripts were qualitatively analyzed to describe conversations concerning the cost and acquisition of new medication prescriptions, frequencies of discussions were described, and multivariate logistic regression was used to examine the predictors of cost discussions. Results: For one third of newly prescribed medications, physicians discussed an aspect of acquisition, including cost and insurance coverage for 12%, logistics of obtaining medications for 18%, and medication supply for 9%. Patients initiated cost or insurance concerns for fewer than 2% of the new medications prescribed. There were 5 discussions about patient out-of-pocket costs and 7 discussions offering tips for cost savings. In multivariate analysis, cost discussions were more likely to occur with patients earning less than $20 000 per year compared with those earning more than $60 000 per year, were less likely to occur with medications prescribed by family physicians or internists compared with cardiologists, and were less likely with medications prescribed to older patients. Conclusions: Physician-patient discussions about new medication cost and other acquisition issues, especially medication affordability, occur infrequently. Because physicians may not recognize patients' financial impediments to acquiring medications, this issue should be raised when prescribing new medications.

AB - Objective: To describe the frequency and content of physician discussions about the cost and acquisition of new medications. Study Design: Qualitative and quantitative study combining patient and physician surveys with transcribed audiotaped office visits from 185 outpatient encounters with 15 family physicians, 18 internists, and 11 cardiologists in 2 Sacramento healthcare systems between January and November 1999, in which 243 new medications were prescribed, Methods: Transcripts were qualitatively analyzed to describe conversations concerning the cost and acquisition of new medication prescriptions, frequencies of discussions were described, and multivariate logistic regression was used to examine the predictors of cost discussions. Results: For one third of newly prescribed medications, physicians discussed an aspect of acquisition, including cost and insurance coverage for 12%, logistics of obtaining medications for 18%, and medication supply for 9%. Patients initiated cost or insurance concerns for fewer than 2% of the new medications prescribed. There were 5 discussions about patient out-of-pocket costs and 7 discussions offering tips for cost savings. In multivariate analysis, cost discussions were more likely to occur with patients earning less than $20 000 per year compared with those earning more than $60 000 per year, were less likely to occur with medications prescribed by family physicians or internists compared with cardiologists, and were less likely with medications prescribed to older patients. Conclusions: Physician-patient discussions about new medication cost and other acquisition issues, especially medication affordability, occur infrequently. Because physicians may not recognize patients' financial impediments to acquiring medications, this issue should be raised when prescribing new medications.

UR - http://www.scopus.com/inward/record.url?scp=33750997311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750997311&partnerID=8YFLogxK

M3 - Article

C2 - 17090222

AN - SCOPUS:33750997311

VL - 12

SP - 657

EP - 664

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 11

ER -